NeoVac was created with the goal of developing the next generation of mRNA vaccines, using ground-breaking new IP for Lipid Nanoparticles developed at Tel-Aviv university. Our researchers at the Harwell Campus are working to expand the scope of the possible for the mRNA vaccine.


R27 Atlas Building, Fermi Avenue, OX11 0QR

Other organisations on campus